GlaxoSmithKline CEO Andrew Witty said Wednesday the company would ensure that if an experimental malaria vaccine works, it would be priced reasonably, Reuters reports. “The vaccine, called Mosquirix [or RTS,S] and the first malaria shot to make it to final-stage trials, is creating a buzz ahead of a conference of 1,500 malaria experts in Nairobi next week,” writes Reuters.
Gates Foundation Praises U.S. Global Health Investments, Calls For 15-Year Goal Of Cutting Child Deaths Worldwide By Nearly Half
As part of a “major push to convince the United States to maintain government spending on worldwide health initiatives, despite the financial crisis and a soaring U.S. budget deficit,” the Bill & Melinda Gates Foundation is urging U.S. policymakers to commit to cutting “the number of child deaths each year, from 9 million to 5 million” by 2025, CNN reports.
CDC Says U.S. H1N1 Vaccine Supplies On The Rise; Senators Question Government’s Handling Of H1N1 Vaccination Program
Supplies of the H1N1 (swine flu) vaccine are steadily increasing in the U.S. and should soon be more widely accessible in the next two weeks, the CDC said on Tuesday, CQ HealthBeat reports. During a press briefing, CDC Director Thomas Frieden said that 22.4 million vaccine doses are now available for states to order (Norman, 10/27).
President Barack Obama declared the H1N1 (swine) flu outbreak a national emergency, the Wall Street Journal reports. “The declaration, which Mr. Obama signed Friday, authorizes the administration to waive or modify certain federal requirements involving Medicare, Medicaid and health-privacy rules to speed treatment,” the newspaper writes (McKay/Simpson/Whalen, 10/26).
Lancet Infectious Diseases Review Examines Progress On Dengue Vaccine “The spread of dengue virus throughout the tropics represents a major, rapidly growing public health problem with an estimated 2.5 billion people at risk of dengue fever and the life-threatening disease, severe dengue,” write the authors of a Lancet Infectious Diseases…
The Washington Post examines H1N1 vaccine supplies across the U.S.: “With only a fraction of the tens of millions of doses of vaccine that authorities predicted would be available arriving in states, cities and towns, public health officials who spent months planning for a massive immunization program are instead scrambling to parcel out their limited supply of nasal sprays and shots,” the newspaper writes.
Agence France-Presse examines how two recent studies have “boosted morale” among HIV vaccine researchers who have struggled for decades to develop a viable vaccine to protect people from the virus.
Wednesday’s release of the WHO, UNICEF and the World Bank joint report on childhood vaccines highlighted gains in recent global vaccination campaigns and also found that nearly 24 million infants worldwide don’t get the recommended first-year vaccination. The following news outlets examined the challenges associated with the expansion of global immunization campaigns to reach this population:
Nigeria Gets $669M Global Fund Grant For Health System Strengthening The Global Fund to Fight AIDS, Tuberculosis and Malaria awarded Nigeria a $669 million Round 8 grant for health system strengthening over five years, This Day/allAfrica.com reports. “During the grant signing ceremony in Abuja yesterday, Chairman of the occasion and…
A joint report by the WHO, UNICEF and the World Bank on worldwide vaccination efforts released Wednesday found “a record 106 million infants were vaccinated last year against life-threatening diseases, but nearly a fifth of the world’s babies still are not protected fully,” the Associated Press reports.